Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester.
This paper discusses the case of a pregnant woman with polychemotherapy during the second trimester of pregnancy for rhabdomyosarcoma of the face and cessation of fetal growth with disappearance of amniotic fluid after the first course of therapy.
Fernandez
H
H
Department of Obstetrics and Gynecology, Hôpital Antoine Beclere, Clamart, France.
Diallo
A
A
Baume
D
D
Papiernik
E
E
D000328:Adult; D000653:Amniotic Fluid; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003609:Dactinomycin / Q000008:administration & dosage / Q000009:adverse effects; D005153:Facial Neoplasms / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005317:Fetal Growth Retardation / Q000139:chemically induced*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D012208:Rhabdomyosarcoma / Q000150:complications / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D003609:Dactinomycin; D014750:Vincristine; D007069:Ifosfamide